| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9157850 | Atherosclerosis | 2005 | 7 Pages |
Abstract
In this large subject cohort, ezetimibe coadministered with simvastatin significantly reduced hs-CRP, suggesting a possible additional anti-inflammatory/anti-atherosclerotic action of combination therapy compared to simvastatin monotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Philip T. Sager, Rachel Capece, Leslie Lipka, John Strony, Bo Yang, Ramachandran Suresh, Yale Mitchel, Enrico Veltri,